Your browser doesn't support javascript.
loading
Cerebellar Volumetry in Ataxias: Relation to Ataxia Severity and Duration.
Ferreira, Mónica; Schaprian, Tamara; Kügler, David; Reuter, Martin; Deike-Hoffmann, Katharina; Timmann, Dagmar; Ernst, Thomas M; Giunti, Paola; Garcia-Moreno, Hector; van de Warrenburg, Bart; van Gaalen, Judith; de Vries, Jeroen; Jacobi, Heike; Steiner, Katharina Marie; Öz, Gülin; Joers, James M; Onyike, Chiadi; Povazan, Michal; Reetz, Kathrin; Romanzetti, Sandro; Klockgether, Thomas; Faber, Jennifer.
Afiliação
  • Ferreira M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Schaprian T; Rhenish Friedrich Wilhelm University of Bonn, Bonn, Germany.
  • Kügler D; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Reuter M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Deike-Hoffmann K; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Timmann D; A.A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Boston, MA, USA.
  • Ernst TM; Department of Radiology, Harvard Medical School, Boston, MA, USA.
  • Giunti P; Department of Neuroradiology, University Hospital Bonn, Bonn, Germany.
  • Garcia-Moreno H; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • van de Warrenburg B; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • van Gaalen J; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • de Vries J; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Jacobi H; Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.
  • Steiner KM; National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK.
  • Öz G; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Joers JM; Department of Neurology, Donders Institute for Brain, Cognition, and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Onyike C; Neurology Department, Rijnstate Hospital, Arnhem, The Netherlands.
  • Povazan M; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Reetz K; Department of Neurology, University Hospital Heidelberg, Heidelberg, Germany.
  • Romanzetti S; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Duisburg, Germany.
  • Klockgether T; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
  • Faber J; Center for Magnetic Resonance Research, Department of Radiology, University of Minnesota, Minneapolis, MN, USA.
Cerebellum ; 2024 Feb 16.
Article em En | MEDLINE | ID: mdl-38363498
ABSTRACT
Cerebellar atrophy is the neuropathological hallmark of most ataxias. Hence, quantifying the volume of the cerebellar grey and white matter is of great interest. In this study, we aim to identify volume differences in the cerebellum between spinocerebellar ataxia type 1 (SCA1), SCA3 and SCA6 as well as multiple system atrophy of cerebellar type (MSA-C). Our cross-sectional data set comprised mutation carriers of SCA1 (N=12), SCA3 (N=62), SCA6 (N=14), as well as MSA-C patients (N=16). Cerebellar volumes were obtained from T1-weighted magnetic resonance images. To compare the different atrophy patterns, we performed a z-transformation and plotted the intercept of each patient group's model at the mean of 7 years of ataxia duration as well as at the mean ataxia severity of 14 points in the SARA sum score. In addition, we plotted the extrapolation at ataxia duration of 0 years as well as 0 points in the SARA sum score. Patients with MSA-C demonstrated the most pronounced volume loss, particularly in the cerebellar white matter, at the late time intercept. Patients with SCA6 showed a pronounced volume loss in cerebellar grey matter with increasing ataxia severity compared to all other patient groups. MSA-C, SCA1 and SCA3 showed a prominent atrophy of the cerebellar white matter. Our results (i) confirmed SCA6 being considered as a pure cerebellar grey matter disease, (ii) emphasise the involvement of cerebellar white matter in the neuropathology of SCA1, SCA3 and MSA-C, and (iii) reflect the rapid clinical progression in MSA-C.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cerebellum Assunto da revista: CEREBRO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cerebellum Assunto da revista: CEREBRO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha